Literature DB >> 3009842

Transfer, by selective breeding, of the pathogenic Mtv-2 endogenous provirus from the GR strain to a wild mouse line free of endogenous and exogenous mouse mammary tumor virus.

D W Morris, L J Young, M B Gardner, R D Cardiff.   

Abstract

The GR laboratory mouse strain has five endogenous proviral copies of the mouse mammary tumor virus (MMTV). One of these, Mtv-2, is unique because it causes mammary carcinomas in virtually 100% of breeding GR females prior to 1 year of age. To facilitate studies of this locus in particular, and mammary tumorigenesis in general, we genetically tailored a new mouse line, WXG-2, which bears Mtv-2 as its only endogenous MMTV provirus. The WXG-2 line was constructed by making hybrids between the GR strain and a wild mouse line free of both endogenous and exogenous MMTV, backcrossing to the MMTV-free line, and fixing the Mtv-2 locus in a population with the desired genotype. Mammary tumors were observed in 5 of the 20 hybrid females carrying the endogenous Mtv-2 provirus. The WXG-2 line represents a new model system for studying MMTV-induced mammary tumorigenesis in the absence of multiple endogenous proviruses.

Entities:  

Mesh:

Year:  1986        PMID: 3009842      PMCID: PMC252907     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Mammary tumors from GR mice contain more than one population of mouse mammary tumor virus-infected cells.

Authors:  J I Macinnes; E C Chan; D H Percy; V L Morris
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

2.  Identification and partial characterization of an endogenous form of mouse mammary tumor virus that is transcribed into the virion-associated RNA genome.

Authors:  T G Fanning; J P Puma; R D Cardiff
Journal:  Nucleic Acids Res       Date:  1980-12-11       Impact factor: 16.971

Review 3.  Retroviruses in feral mice.

Authors:  M B Gardner; S Rasheed
Journal:  Int Rev Exp Pathol       Date:  1982

4.  Development of a mouse mammary tumor virus-negative mouse strain: a new system for the study of mammary carcinogenesis.

Authors:  J C Cohen; V L Traina; T Breznik; M Gardner
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

5.  Selective amplification of mouse mammary tumor virus in mammary tumors of GR mice.

Authors:  T G Fanning; J P Puma; R D Cardiff
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

6.  Proviruses of mouse mammary tumor virus in normal and neoplastic tissues from GR and C3Hf mouse strains.

Authors:  J C Cohen; H E Varmus
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

7.  Methylation and amplification of mouse mammary tumor virus DNA in normal, premalignant, and malignant cells of GR/A mice.

Authors:  T G Fanning; A B Vassos; R D Cardiff
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

8.  Mammary tumor virus DNA as a marker for genotypic variance within hormone-responsive GR mouse mammary tumors.

Authors:  R Michalides; E Wagenaar; M Sluyser
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

9.  Restriction endonuclease studies of hyperplastic outgrowth lines from BALB/cfC3H mouse hyperplastic mammary nodules.

Authors:  R D Cardiff; T G Fanning; D W Morris; R L Ashley; L J Faulkin
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

10.  Mammary tumor induction loci in GR and DBAf mice contain one provirus of the mouse mammary tumor virus.

Authors:  R Michalides; R van Nie; R Nusse; N E Hynes; B Groner
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

View more
  2 in total

1.  A novel V beta 2-specific endogenous mouse mammary tumor virus which is capable of producing a milk-borne exogenous virus.

Authors:  N Niimi; W Wajjwalku; Y Ando; N Nakamura; M Ueda; Y Yoshikai
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 2.  Mus tales: a hands-on view.

Authors:  Lawrence J T Young
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-25       Impact factor: 2.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.